He will present his award lecture, titled “Quantitative Biomarkers and Disease Subtypes: The Building Blocks of Precision Medicine,” on Thursday, December 10, at 9 a.m. CT.
Dr․ Brugge, Director of the Ludwig Center at Harvard Medical School, will deliver a lecture titled "Genetic and epigenetic determinants of BRCA1/2 tumorigenesis."
